Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Baiba Kokina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Association of inflammatory biomarkers with atherosclerotic plaque composition and clinical course of obstructive coronary artery disease
Kokina, B. (Project leader), Trušinskis, K. (Supervisor) & Tretjakovs, P. (Supervisor)
2/10/23 → 30/09/27
Project: PhD projects
-
Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients
Trusinskis, K., Lapsovs, M., Kokina, B., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Grave, A., Kumsars, I. & Erglis, A., Nov 2023, In: European Heart Journal. 44, Suppl.2, 1 p., ehad655.1313.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study
Vasiljevs, D. (Corresponding Author), Kakurina, N., Pontaga, N., Kokina, B., Osipovs, V., Sorokins, N., Pikta, S., Trusinskis, K. & Lejnieks, A., Feb 2023, In: Medicina (Kaunas, Lithuania). 59, 2, 270.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)21 Downloads (Pure) -
Effects of PCSK9 gene silencing by small interfering RNA inclisiran on coronary atherosclerotic plaque lipid content
Trusinskis, K., Kokina, B., Lapsovs, M., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Kumsars, I. & Erglis, A., Aug 2023, In: Atherosclerosis. 379, Suppl.1, p. S58 SS162.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
NIRS-Detected Lipid-Rich Plaques Are Highly Responsive to Novel Escalated LDL-C Reduction Therapy
Trusinskis, K., Kokina, B., Lapsovs, M., Karantajere, M., Knoka, E., Caunite, L., Jegere, S., Narbute, I., Sondore, D., Grave, A., Kumsars, I. & Erglis, A., 24 Oct 2023, In: Journal of the American College of Cardiology. 82, 17, Suppl., p. B223Research output: Contribution to journal › Meeting Abstract › peer-review
-
Atrial fibrillation recurrence prevention after electrical cardioversion in high-risk patients – benefits of non-antiarrhythmic drugs
Kokina, B. (Corresponding Author), Kalejs, O., Maca, A., Strelnieks, A., Jubele, K., Rudaka, I., Apsite, K. & Lejnieks, A., 2021, In: Open Cardiovascular Medicine Journal. 15, 1, p. 38-46 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile8 Downloads (Pure)
-
Spironolactone for Atrial Fibrillation Recurrence Reduction after Successful Electrical Cardioversion
Kokina, B. (Speaker), Kalējs, O. (Co-author), Mača-Kalēja, A. (Co-author), Strēlnieks, A. (Co-author), Jubele, K. (Co-author) & Lejnieks, A. (Co-author)
29 Mar 2023Activity: Talk or presentation types › Poster presentation
-
Triglyceride-Associated Coronary Lumen Area Increase in Patients Receiving Inclisiran as Add-on Lipid-Lowering Treatment
Kokina, B. (Speaker), Trušinskis, K. (Co-author), Lapsovs, M. (Co-author), Karantajere, M. (Co-author), Knoka, E. (Co-author), Caunite, L. (Co-author), Jegere, S. (Co-author), Narbute, I. (Co-author), Sondore, D. (Co-author), Kumsars, I. (Co-author) & Erglis, A. (Co-author)
29 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Indirect antiarrhythmic effects of renin-angiotensin-aldosterone system inhibition for arrhythmia recurrence prevention after electrical cardioversion for persistent atrial fibrillation
Kokina, B. (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation